Tension-Type Headache and Masseter Thickness in Fibromyalgia

Ankara City Hospital

Status: Completed

Conditions: Fibromyalgia

Treatments: Other: scales; Other: masseter muscle thickness measurement

Study type: Observational

Funder types: Other

Identifiers

NCT06713278

CORUM-PMR-DRHENY-01

Details and patient eligibility

About

This study aims to investigate the relationship between tension-type headaches and masseter muscle thickness in women with fibromyalgia syndrome (FMS) and to explore the potential for new therapeutic approaches in the treatment of both headaches and FMS. Additionally, the study seeks to evaluate the impact of headaches on the quality of life in individuals with FMS.

Does tension-type headache associate with increased masseter muscle thickness in women with fibromyalgia syndrome (FMS)? Does tension-type headache negatively impact the quality of life in women with FMS?

Full description

Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread musculoskeletal pain, fatigue, cognitive dysfunction, and tenderness, affecting approximately 5% of the global population, predominantly women. Central sensitization plays a key role in its pathophysiology. Tension-type headaches, the most common in FMS (59.01%), are associated with pericranial muscle sensitivity, anxiety, and reduced quality of life. Increased masseter muscle activity has been observed in tension-type headaches, but its relationship with FMS remains unexplored.

Enrollment: 94 patients

Sex: Female

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Women aged 18-65 years.
• Diagnosed with fibromyalgia syndrome (FMS) according to the 2016 American College of Rheumatology (ACR) diagnostic criteria.
• At least one year since the FMS diagnosis.
• Chronic tension-type headache lasting for at least six months.
• Diagnosed with tension-type headache by a neurologist based on the International Classification of Headache Disorders (ICHD-3) criteria.

Exclusion criteria

• Patients with neurological or psychiatric disorders.
• Patients using medications related to the central nervous system.
• Those with temporomandibular dysfunction.
• Patients with rheumatologic diseases.
• Individuals undergoing dental treatment or using dental prostheses.
• Those with facial tumors or a history of facial surgery.
• Pregnant women.

Trial design

94 participants in 3 patient groups

fibromyalgia with tension type headache

Description:

fibromyalgia with tension type headache

Treatment:

Other: masseter muscle thickness measurement

Other: scales

fibromyalgia without tension type headache

Description:

fibromyalgia without tension type headache

Treatment:

Other: masseter muscle thickness measurement

Other: scales

control group

Description:

control group

Treatment:

Other: masseter muscle thickness measurement

Other: scales